Serial 99672940
Live / Allowed — Published for opposition (as of 27 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99672940
- Mark type
- Design / logo
- Filed
- 26 Feb 2026
- Published for opposition
- 27 Oct 2026
- Attorney of record
- Christopher M Hanes
Goods and services
- Class 035 — Advertising and business services: Providing consumer product information in the field of pharmaceuticals for the treatment of oncological diseases and disorders; business administration of medication reimbursement programs and services related to pharmaceuticals for the treatment of oncological diseases and disorders
- Class 036 — Insurance and financial services: Providing information in the field of healthcare insurance benefits related to pharmaceuticals for the treatment of oncological diseases and disorders; insurance benefits verification in the field of healthcare insurance benefits related to pharmaceuticals for the treatment of oncological diseases and disorders; providing financial assistance for medical copays to patients; providing financial assistance for medical payments for patients in need; copayment assistance programs, namely, providing financial assistance to patients for prescription medications for the treatment of diseases and disorders; financial administration of medication reimbursement programs and services in the field of pharmaceuticals for the treatment of diseases and disorders
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of pharmaceuticals for the treatment of oncological diseases and disorders; providing medical information in the field of patient access to and reimbursement for pharmaceuticals and safe and appropriate use and distribution of pharmaceuticals; providing patient access to pharmaceuticals, namely, dispensing of pharmaceuticals; health care services, namely, providing patient access programs to provide pharmaceuticals to eligible patients; providing medical information to patients, health care providers, medical office staff, pharmaceutical prescribers, and pharmacies in the field of pharmaceuticals for the treatment of oncological diseases and disorders, access to pharmaceuticals, and safe and appropriate use and distribution of pharmaceuticals.
- Class 045 — Legal and security services: Providing personal support services for patients and families of patients, namely, emotional counseling and emotional support services; providing information related to emotional counseling and support services for patients and families of patients with diseases and disorders
Owner
- Nuvalent, Inc., Wilmington, DE, US
- Nuvalent, Inc., Wilmington, DE, US
Prosecution history
- 27 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Oct 2026 — PUBLISHED FOR OPPOSITION
- 21 Oct 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Sept 2026 — USE AMENDMENT ACCEPTED
- 22 Sept 2026 — AMENDMENT TO USE PROCESSING COMPLETE
- 22 Sept 2026 — USE AMENDMENT FILED
- 22 Sept 2026 — TEAS AMENDMENT OF USE RECEIVED
- 10 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED